超声BI-RADS联合血CA15-3和CEA在乳腺肿物诊断中的价值研究

doi:10.11904/j.issn.1002-3070.2020.04.010

实用肿瘤学杂志 ›› 2020, Vol. 34 ›› Issue (4): 347-351.doi: 10.11904/j.issn.1002-3070.2020.04.010

超声BI-RADS联合血CA15-3和CEA在乳腺肿物诊断中的价值研究

刘思奇¹, 边娜娜², 苏亚娟¹

1.哈尔滨医科大学附属肿瘤医院临床检验科(哈尔滨 150081);
2.哈尔滨医科大学附属肿瘤医院心肺功能科

收稿日期:2020-02-23 发布日期:2020-08-17
通讯作者: 苏亚娟,E-mail:suyajuan1977@sina.com
作者简介:刘思奇,女,(1990-),硕士,住院医师,从事肿瘤免疫与分子生物学的研究。

Research on the value of ultrasound BI-RADS combined with serum CA15-3 and CEA in the diagnosis of breast tumors

LIU Siqi¹, BIAN Nana², SU Yajuan¹

1. Department of Clinical Laboratory,Harbin Medical University Cancer Hospital,Harbin 150081,China;
2. Department of Cardiopulmonary Function Examination Room,Harbin Medical University Cancer Hospital

Received:2020-02-23 Published:2020-08-17

摘要/Abstract

摘要： 目的探讨超声BI-RADS与血CA15-3和CEA联合检测在乳腺肿物中的诊断价值。方法选择2019年6月—2019年12月乳腺肿物患者111例,以病理结果为金标准,分析超声BI-RADS、血CA15-3和CEA联合对乳腺肿物诊断的敏感性及准确性。结果病理示良性病变43例,乳腺癌68例。与良性病变患者相比,乳腺癌患者血CA15-3和CEA均升高(P＜0.05)。乳腺癌患者CA15-3和CEA呈正相关。超声BI-RADS、血CA15-3和CEA联合对乳腺癌诊断的敏感性达到73.5%,准确性升高至83.8%,AUC提高到0.957,均高于三者各自单独使用时的诊断效果。结论超声BI-RADS、血CA15-3和CEA联合检测是一种提高乳腺肿物诊断敏感性和准确率的有效方法。

关键词: 乳腺癌, 超声检查, 糖类抗原15-3, 癌胚抗原

Abstract: Objective The aim of this study was to investigate the diagnostic value of ultrasound BI-RADS combined detection with serum CA15-3 and CEA in breast tumors. Methods A total of 111 patients with breast tumors from June 2019 to December 2019 were selected.The pathological results were used as the gold standard to analyze the sensitivity and accuracy of ultrasound BI-RADS,serum CA15-3 and CEA in the diaganosis of breast tumor. Results Pathological results showed 43 cases of benign lesions and 68 cases of breast cancer.Compared with patients with benign lesions,the increase in serum CA15-3 and CEA in breast cancer patients was statistically different.There was also a positive correlation between the increase of CA15-3 and CEA with breast cancer.By combining ultrasound BI-RADS with serum CA15-3 and CEA,the sensitivity for breast cancer diagnosis reached 73.5%,the accuracy increased to 83.8%,and the AUC of the ROC curve was increased to 0.957,which was higher than the results when they were used alone. Conclusion The combined detection of ultrasound BI-RADS,serum CA15-3 and CEA is an effective method to improve the sensitivity and accuracy of breast tumor diagnosis.

Key words: Breast cancer, Ultrasound examination, Carbohydrate antigen 15-3, Carcinoembryonic antigen

中图分类号:

R737.9

刘思奇, 边娜娜, 苏亚娟. 超声BI-RADS联合血CA15-3和CEA在乳腺肿物诊断中的价值研究[J]. 实用肿瘤学杂志, 2020, 34(4): 347-351.

LIU Siqi, BIAN Nana, SU Yajuan. Research on the value of ultrasound BI-RADS combined with serum CA15-3 and CEA in the diagnosis of breast tumors[J]. Journal of Practical Oncology, 2020, 34(4): 347-351.

0
/ / 推荐

导出引用管理器 EndNote|Reference Manager|ProCite|BibTeX|RefWorks

链接本文: http://journal09.magtechjournal.com/Jwk3_syzlxzz/CN/10.11904/j.issn.1002-3070.2020.04.010

http://journal09.magtechjournal.com/Jwk3_syzlxzz/CN/Y2020/V34/I4/347

参考文献

1 Bray F,Ferlay J,Soerjomataram I,et al.Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2018,68(6):394-424.
2 中国抗癌协会乳腺癌诊治指南与规范(2019年版)[J].中国癌症杂志,2019,29(8):609-680.
3 Chang TH,Hsu HH,Chou YC,et al.The values of combined and sub-stratified imaging scores with ultrasonography and mammography in breast cancer subtypes[J].PLoS One,2015,10(12):e0145390.
4 孙可欣,郑荣寿,顾秀瑛,等.2000-2014年中国肿瘤登记地区女性乳腺癌发病趋势及年龄变化情况分析[J].中华预防医学杂志,2018,52(06):567-572.
5 Sun H,Song B,Zhang M.Analysis of cancer incidence and mortality data in Heilongjiang province cancer registries,China,2015[J].Oncology and Translational Medicine,2019,5(4):182-187.
6 Stein RG,Wollschläger D,Kreienberg R,et al.The impact of breast cancer biological subtyping on tumor size assessment by ultrasound and mammography-a retrospective multicenter cohort study of 6543 primary breast cancer patients[J].BMC Cancer,2016,16:459.
7 Wang Y,Wang J,Wang H,et al.Comparison of mammography and ultrasonography for tumor size of DCIS of breast cancer[J].Curr Med Imaging Rev,2019,15(2):209-213.
8 Carlsen J,Ewertsen C,Sletting S,et al.Ultrasound elastography in breast cancer diagnosis[J].Ultraschall Med,2015;36(6):550-565.
9 Harris L,Fritsche H,Mennel R,et al.American society of clinical oncology 2007 update of recommendations for the use of tumor markers in breast cancer[J].J Clin Oncol,2007,25(33):5287-5312.
10 Wang W,Xu X,Tian B,et al.The diagnostic value of serum tumor markers CEA,CA19-9,CA125,CA15-3,and TPS in metastatic breast cancer[J].Clin Chim Acta,2017,470:51-55.
11 曹涤非,黄国庆,薛佳莹,等.CA153在乳腺癌免疫治疗中的作用[J].实用肿瘤学杂志,2019,33(6):566-569.
12 Kirwan A,Utratna M,O'Dwyer ME,et al.Glycosylation-based serum biomarkers for cancer diagnostics and prognostics[J].Biomed Res Int,2015,2015:490531.
13 Dai D,Chen B,Tang H,et al.Nomograms for predicting the prognostic value of pre-therapeutic CA15-3 and CEA serum levels in TNBC patients[J].PLoS One,2016,11(8):e0161902.

[1]	赵仁成, 林子棠, 余卫军, 雷林, 刘峥, 徐英, 郭艳芳, 彭绩. 2017—2019年深圳市宝安区40~74岁常住居民五癌风险流行状况分析[J]. 实用肿瘤学杂志, 2020, 34(4): 315-320.
[2]	仝潇, 邢佳妮, 王丽虹. 长链非编码RNA HCP5通过调控凋亡通路促进三阴性乳腺癌的研究[J]. 实用肿瘤学杂志, 2020, 34(4): 321-327.
[3]	张锐, 李志高. 粘液性乳腺癌的临床研究进展[J]. 实用肿瘤学杂志, 2020, 34(4): 377-381.
[4]	陈都, 钱诚. 乳腺癌肿瘤微环境中间质细胞介导的化疗耐药性研究进展[J]. 实用肿瘤学杂志, 2020, 34(4): 382-386.
[5]	谢贤鑫, 韦军, 邱佳鑫, 王聪, 姜大庆. 乳腺癌新辅助化疗残余肿瘤组织病理信息与预后分析[J]. 实用肿瘤学杂志, 2020, 34(3): 225-231.
[6]	李慧, 庞达. 三阳型乳腺癌的临床病理学特点及辅助治疗[J]. 实用肿瘤学杂志, 2020, 34(3): 262-265.
[7]	赵云霞, 牛波. LncRNA NBAT1通过调控miR-3664-5p/Caspase 9分子轴对人乳腺癌细胞增殖的影响[J]. 实用肿瘤学杂志, 2020, 34(1): 24-29.
[8]	李国政, 庞达. HER2阳性乳腺癌治疗的研究进展[J]. 实用肿瘤学杂志, 2020, 34(1): 74-78.
[9]	曹涤非, 黄国庆, 薛佳莹, 吴琼, 王雷, 李瑶. CA153在乳腺癌免疫治疗中的作用[J]. 实用肿瘤学杂志, 2019, 33(6): 566-569.
[10]	沈依哲, 郭宝良. 初诊Ⅳ期乳腺癌的局部治疗研究进展[J]. 实用肿瘤学杂志, 2019, 33(6): 575-578.
[11]	师镘茹, 鄂明艳. 放疗延迟对乳腺癌不同分子亚型患者预后的影响[J]. 实用肿瘤学杂志, 2019, 33(5): 431-435.
[12]	李磊 , 张清媛. 乳腺癌抗肿瘤血管治疗的临床进展[J]. 实用肿瘤学杂志, 2019, 33(5): 461-465.
[13]	王宇, 乔娟娟, 张磊, 刘四卫 , 杨树才. 类固醇激素在乳腺癌中的作用及对肿瘤干细胞的影响[J]. 实用肿瘤学杂志, 2019, 33(5): 466-470.
[14]	刘尔钰, 杨昊, 梁国华, 赵晏方, 赵文辉. CDK4/6抑制剂联合mTOR抑制剂在乳腺癌中的作用机制[J]. 实用肿瘤学杂志, 2019, 33(5): 476-480.
[15]	安巍巍, 唐雅莉, 赵莲花, 杨悦, 王新玲. 红松松塔提取物多聚苯丙素-多糖复合物诱导人乳腺癌MCF-7细胞凋亡[J]. 实用肿瘤学杂志, 2019, 33(4): 289-293.

超声BI-RADS联合血CA15-3和CEA在乳腺肿物诊断中的价值研究

Research on the value of ultrasound BI-RADS combined with serum CA15-3 and CEA in the diagnosis of breast tumors

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价